Sarepta Therapeutics (SRPT) Share-based Compensation Growth (3y) (2013 - 2026)
Sarepta Therapeutics (SRPT) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
4.80% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
10.78% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Sarepta Therapeutics |
1.84 Bn |
1.16 Bn |
291.52 Mn |
-6.54% |
| Date | Value |
|---|
| Mar 31, 2026 |
-6.54% |
| Dec 31, 2025 |
-3.30% |
| Sep 30, 2025 |
-31.23% |
| Jun 30, 2025 |
-28.89% |
| Mar 31, 2025 |
12.37% |
| Dec 31, 2024 |
33.29% |
| Sep 30, 2024 |
17.67% |
| Jun 30, 2024 |
20.31% |
| Mar 31, 2024 |
16.62% |
| Dec 31, 2023 |
15.77% |
| Sep 30, 2023 |
21.37% |
| Jun 30, 2023 |
19.73% |
| Mar 31, 2023 |
19.75% |
| Dec 31, 2022 |
31.72% |
| Sep 30, 2022 |
34.76% |
| Jun 30, 2022 |
73.32% |
| Mar 31, 2022 |
21.95% |
| Dec 31, 2021 |
32.47% |
| Sep 30, 2021 |
32.42% |
| Jun 30, 2021 |
23.76% |
